In recent years, we have begun to recognise the rising threat of Multidrug Resistant Organisms (MDORs), and the profound impact that healthcare associated infections (HCAIs), such as MRSA, can have on both patient safety and quality of care.
The updated and signif.
HCAIs prolong patients\' hospital stays, and increase morbidity as well as mortality rates, yet diagnosing and treating these infections is a costly process that can place intense pressure on already limited healthcare resources.
In recent years, we have begun to recognise the rising threat of Multidrug Resistant Organisms (MDORs), and the profound impact that healthcare associated infections (HCAIs), such as MRSA, can have on both patient safety and quality of care